Beacon Pointe Advisors, LLC Novo Nordisk A S Transaction History
Beacon Pointe Advisors, LLC
- $8.76 Billion
- Q1 2025
A detailed history of Beacon Pointe Advisors, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Beacon Pointe Advisors, LLC holds 128,159 shares of NVO stock, worth $6.91 Million. This represents 0.1% of its overall portfolio holdings.
Number of Shares
128,159
Previous 37,900
238.15%
Holding current value
$6.91 Million
Previous $3.26 Million
172.98%
% of portfolio
0.1%
Previous 0.04%
Shares
20 transactions
Others Institutions Holding NVO
# of Institutions
1,759Shares Held
338MCall Options Held
11MPut Options Held
15.9M-
Jennison Associates LLC18.8MShares$1.02 Billion0.93% of portfolio
-
Bank Of America Corp Charlotte, NC14.8MShares$798 Million0.08% of portfolio
-
Loomis Sayles & CO L P12.4MShares$668 Million1.24% of portfolio
-
Morgan Stanley New York, NY12.3MShares$665 Million0.06% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa11.9MShares$640 Million0.36% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $122B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...